Resvita Bio

About:

Resvita Bio develops and manufactures engineered probiotics for use in treatment if skin related diseases including cancer.

Website: https://resvitabio.com/

Twitter/X: resvita_bio

Top Investors: National Institute of Allergy and Infectious Diseases, Pioneer Fund, National Institutes of Health

Description:

Total Funding Amount:

$2.28M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Berkeley, California, United States

Founded Date:

2021-01-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2024-09-24

IPO Status:

Private

Industries: